Market Cap 1.73B
Revenue (ttm) 0.00
Net Income (ttm) -47.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,645,400
Avg Vol 1,839,978
Day's Range N/A - N/A
Shares Out 128.23M
Stochastic %K 83%
Beta 0.83
Analysts Strong Sell
Price Target $20.82

Company Profile

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough i...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 304 2499
Address:
195 Church Street, 16th Floor, New Haven, United States
Bfunk17
Bfunk17 Dec. 7 at 3:01 PM
$TRVI 226,381 Shares in Trevi Therapeutics, Inc. $TRVI Bought by Prudential Financial Inc. https://share.google/1rAUya7Ih2RLyhK6S
1 · Reply
Chris2bucks4life
Chris2bucks4life Dec. 4 at 7:26 PM
0 · Reply
Bfunk17
Bfunk17 Dec. 4 at 4:37 PM
$TRVI Hang in there, folks. Really good CFO vet brought in. Adjust expectations to early-mid Q2 zone for an announcement. I believe there is interest from multiple suitors driving this action. Should be all good news in the end for holders. I'd def count out a Dec miracle at this point, though. Which usually is better in the end if you have multiple bidders. Let's maximize this opp.
2 · Reply
Bfunk17
Bfunk17 Dec. 4 at 1:00 PM
0 · Reply
Bfunk17
Bfunk17 Dec. 4 at 12:45 PM
$TRVI Transitional CFO finally announced. David Hastings will oversee the BO and transition to the BP.
1 · Reply
Chris2bucks4life
Chris2bucks4life Dec. 3 at 8:30 PM
$TRVI https://seekingalpha.com/article/4849903-trevi-therapeutics-buy-rating-for-haduvio-treating-chronic-cough-in-ipf-and-beyond?utm_source=webull.com&utm_medium=referral&feed_item_type=article
1 · Reply
Soheil444
Soheil444 Dec. 2 at 11:44 PM
$TRVI So is this share price the actual value or up here bc of rumor buyout ?
1 · Reply
Chris2bucks4life
Chris2bucks4life Dec. 2 at 9:49 PM
$TRVI here comes the rumor https://seekingalpha.com/news/4527856-trevi-therapeutics-edges-higher-amid-takeover-speculation?utm_source=webull.com&utm_medium=referral&feed_item_type=news
2 · Reply
Bfunk17
Bfunk17 Dec. 2 at 3:06 PM
$TRVI Continued high confidence in this end game. Feels like an Xmas surprise for us. Good volume, upward momentum, and SI keeps shaving off. There is zero appetite by the Tutes, who literally hold the entire float, to hedge at this point. Wonderful indicators for us retail holders as the BO should come . Enjoy the show, folks.
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 10:27 AM
0 · Reply
Latest News on TRVI
Trevi Therapeutics to Participate in Upcoming August Conferences

Jul 29, 2025, 7:30 AM EDT - 4 months ago

Trevi Therapeutics to Participate in Upcoming August Conferences


Trevi Therapeutics to Participate in Upcoming June Conferences

May 29, 2025, 7:30 AM EDT - 6 months ago

Trevi Therapeutics to Participate in Upcoming June Conferences


Trevi Therapeutics, Inc. (TRVI) Q1 2025 Earnings Call Transcript

May 11, 2025, 4:16 AM EDT - 7 months ago

Trevi Therapeutics, Inc. (TRVI) Q1 2025 Earnings Call Transcript


Trevi Therapeutics, Inc. (TRVI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 6:47 PM EDT - 9 months ago

Trevi Therapeutics, Inc. (TRVI) Q4 2024 Earnings Call Transcript


Bfunk17
Bfunk17 Dec. 7 at 3:01 PM
$TRVI 226,381 Shares in Trevi Therapeutics, Inc. $TRVI Bought by Prudential Financial Inc. https://share.google/1rAUya7Ih2RLyhK6S
1 · Reply
Chris2bucks4life
Chris2bucks4life Dec. 4 at 7:26 PM
0 · Reply
Bfunk17
Bfunk17 Dec. 4 at 4:37 PM
$TRVI Hang in there, folks. Really good CFO vet brought in. Adjust expectations to early-mid Q2 zone for an announcement. I believe there is interest from multiple suitors driving this action. Should be all good news in the end for holders. I'd def count out a Dec miracle at this point, though. Which usually is better in the end if you have multiple bidders. Let's maximize this opp.
2 · Reply
Bfunk17
Bfunk17 Dec. 4 at 1:00 PM
0 · Reply
Bfunk17
Bfunk17 Dec. 4 at 12:45 PM
$TRVI Transitional CFO finally announced. David Hastings will oversee the BO and transition to the BP.
1 · Reply
Chris2bucks4life
Chris2bucks4life Dec. 3 at 8:30 PM
$TRVI https://seekingalpha.com/article/4849903-trevi-therapeutics-buy-rating-for-haduvio-treating-chronic-cough-in-ipf-and-beyond?utm_source=webull.com&utm_medium=referral&feed_item_type=article
1 · Reply
Soheil444
Soheil444 Dec. 2 at 11:44 PM
$TRVI So is this share price the actual value or up here bc of rumor buyout ?
1 · Reply
Chris2bucks4life
Chris2bucks4life Dec. 2 at 9:49 PM
$TRVI here comes the rumor https://seekingalpha.com/news/4527856-trevi-therapeutics-edges-higher-amid-takeover-speculation?utm_source=webull.com&utm_medium=referral&feed_item_type=news
2 · Reply
Bfunk17
Bfunk17 Dec. 2 at 3:06 PM
$TRVI Continued high confidence in this end game. Feels like an Xmas surprise for us. Good volume, upward momentum, and SI keeps shaving off. There is zero appetite by the Tutes, who literally hold the entire float, to hedge at this point. Wonderful indicators for us retail holders as the BO should come . Enjoy the show, folks.
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 10:27 AM
0 · Reply
Stockinvestor77
Stockinvestor77 Dec. 2 at 5:19 AM
$TRVI great pick for 2026. Love how there are so few on this board and under 2k watchers 97% owned by institutions.
1 · Reply
jlcrane
jlcrane Dec. 1 at 9:10 PM
$TRVI Who bought 5 million shares at $13.30 on the close?
3 · Reply
jlcrane
jlcrane Dec. 1 at 9:03 PM
$TRVI Who bought 5 million shares at $3.30 on the close?
1 · Reply
Soheil444
Soheil444 Dec. 1 at 6:27 PM
$TRVI wheres our buyout ? 😜
1 · Reply
Chris2bucks4life
Chris2bucks4life Dec. 1 at 5:14 PM
$TRVI grabbed a few more market is a disaster today
0 · Reply
ScreenerIQ
ScreenerIQ Nov. 30 at 10:13 PM
Some #stocks showing strong relative strength. Please DYOResearch. (Image now added.) Some examples: $ORLA $ARMN $IAG $TRVI $TTMI #stockmarket #investing #trading
0 · Reply
ScreenerIQ
ScreenerIQ Nov. 30 at 7:54 PM
Some #Stocks showing strong relative strength. Please DYOResearch. Some examples: $ORLA $ARMN $IAG $TRVI $TTMI #StockMarket #investing #Trading
0 · Reply
StocketShip
StocketShip Nov. 28 at 11:32 PM
$TRVI I hope they don't consider taking a buyout this early, but if they did, what would a fair price for shareholders be please?
1 · Reply
Chris2bucks4life
Chris2bucks4life Nov. 28 at 5:13 PM
$TRVI sorry mms you cant have my shares
0 · Reply
dixiebull
dixiebull Nov. 27 at 10:23 PM
$SMX fantastic play from 5.50 per watchlist to 35.68, we want 25 to hold nowand if not then 20. No telling where it goes but we will watch price action $TMC ramped up afterhoursto 8.30, now holding 7.25. If 7 can hold it can break 8 for 10 $CODI afterhours move to 7.89, see if 7.50 holds for a break of 8 to 8.50 $GANX moved to 3.40, see if 3 holds for a move to 3.50 and 4 $TRVI nice day for this one, to 13.773, see if 13 holds for a move to 13.50/14
1 · Reply
BioTechHealthX
BioTechHealthX Nov. 27 at 4:50 AM
$TRVI Trevi Therapeutics reported a reduced Q3 net loss of $11.8M and $0.08 per share, signaling stronger financial discipline. Discover why TRVI’s progress and late-stage pipeline create major upside potential for investors. https://biotechhealthx.com/biotech-news/trevi-therapeutics-trvi-narrows-q3-loss-to-11-8m-as-haduvio-advances-toward-major-milestone/
0 · Reply
JustCloseTheDeal
JustCloseTheDeal Nov. 27 at 2:26 AM
$TRVI This is an interesting room. Quiet. In the IOVA room there would be 75 gifs, 150 posts all pounding the table. It's very civilized. But, it was pretty interesting with all the shares and calls being gathered up for what seems like a feast coming. Remarkable move, caught fire at 11:08am like someone threw a match at the paper in bookie joint. And the $12 calls .. 1000 calls at 11:09am. I'm just stopping by for the band.
2 · Reply